No Data
No Data
US stock outlook | Wall Street begins to discuss the possibility of interest rate hikes! The three major index futures collectively weakened; Intra-Cellular surged nearly 35% in pre-market trading! It will be acquired by Johnson & Johnson for billions.
Tesla fell 3% before the market opened, as the largest Retirement Fund in Europe liquidated its shares; the yield on the 10-year US Treasury is aiming for 5%! The Global bond market is in turmoil.
The expectation of interest rate cuts by the Federal Reserve has cooled, can the Earnings Reports season sustain the bull market for U.S. stocks?
As the Federal Reserve is unlikely to cut interest rates as quickly as expected, corporate earnings growth has become more crucial for the performance of US stocks.
Top Analyst: There are still 2 years before the Technology stock bubble bursts.
Analysts predict that when NVIDIA and other Hardware stocks start to underperform significantly against investor expectations, the bubble will begin to burst.
The Growth Tech stocks in the U.S. market are experiencing a Top Reversal, how to use Options to seize good entry opportunities?
On one hand, if entering the market too quickly, stock prices may fall unexpectedly, potentially resulting in significant losses; on the other hand, if the "bottom guessing" fails, missing the best timing for positioning may lead to missing the desired price for the stocks. In this situation, the flexible use of several options strategies may help the trade align more with market trends.
Express News | US tightens its grip on AI chip flows across the globe
U.S. Stock Market Insights | Delta Air Lines has scored big! Stock prices hit a new high, with performance and outlook both exceeding expectations; a $16.4 billion acquisition of Calpine, Energy giant CEG surged by 25.16%.
The Medical merger and acquisition frenzy has started again! It is rumored that Johnson & Johnson is in talks to acquire the biopharmaceutical company Intra-Cellular Therapies Inc., which focuses on treating central nervous system diseases, and its stock price has soared nearly 15%.